Updates

DOSE OF REALITY: VOTERS WANT CANDIDATES TALKING ABOUT DRUG PRICES AND FOCUSED ON HOLDING BIG PHARMA ACCOUNTABLE

Dec 6, 2023

KFF Survey Finds Americans Want White House Contenders Talking Rx Prices, Read More

BIG PHARMA WATCH: PHARMA PATENTS INVALIDATED MORE THAN ANY OTHER INDUSTRY FOR MISREPRESENTED OR OMITTED INFORMATION

Nov 17, 2023

Analysis Finds Bogus and Faulty Patents Contribute to Rising Prescription Drug Read More

BIG PHARMA EARNINGS WATCH: ELI LILLY, GLAXOSMITHKLINE AND ASTRAZENECA

Nov 14, 2023

Another Blockbuster Quarter for Profits as Big Pharma Maintains Read More

CSRXP APPLAUDS FTC CRACKDOWN ON BIG PHARMA’S FLAGRANT ABUSE OF THE PATENT SYSTEM

Nov 7, 2023

Commission Targets More Than 100 Patents on Brand Name Products Listed in the Read More

BIG PHARMA EARNINGS WATCH: ABBVIE AND AMGEN

Nov 3, 2023

Another Series of Strong Earnings Reports For Brand Name Giants Fueled by Read More

BIG PHARMA WATCH: BIG PHARMA HIKED PRICES ON MORE THAN 100 MEDICATIONS ABOVE THE RATE OF INFLATION THIS SUMMER

Nov 2, 2023

New Analysis Finds Drug Companies Continue to Price-Gouge American Patients, Read More

BIG PHARMA EARNINGS WATCH: NOVARTIS, MERCK AND BRISTOL MYERS SQUIBB

Oct 27, 2023

More Q3 Earnings From Big Pharma Giants Top Wall Street Expectations Following Read More

BIG PHARMA WATCH: ONCOLOGISTS WHO RECEIVED BIG PHARMA KICKBACKS WERE MORE LIKELY TO PRESCRIBE HIGHER PRICED AND LESS EFFECTIVE DRUGS

Oct 27, 2023

Research Exposes How Big Pharma’s Self-Serving Kickbacks Increase Costs and Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Oct 20, 2023

Big Pharma Giant Kicks Off Q3 Earnings After Hiking Prices More Than 40 Times Read More